Bioqual Price to Free Cash Flow Ratio 2012-2026 | BIOQ
Historical price to free cash flow ratio values for Bioqual (BIOQ) since 2012.
| Bioqual Price to Free Cash Flow Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM FCF per Share | Price to FCF Ratio |
| 2026-06-12 | 32.50 | 4.74 | |
| 2026-02-28 | 37.51 | $6.85 | 5.47 |
| 2025-11-30 | 38.51 | $7.14 | 5.39 |
| 2025-08-31 | 43.19 | $5.94 | 7.27 |
| 2025-05-31 | 45.00 | $3.03 | 14.87 |
| 2025-02-28 | 60.00 | $0.36 | 167.04 |
| 2024-11-30 | 67.50 | $1.96 | 34.52 |
| 2024-08-31 | 69.47 | $8.99 | 7.72 |
| 2024-05-31 | 71.95 | $9.80 | 7.34 |
| 2024-02-29 | 70.00 | $8.33 | 8.41 |
| 2023-11-30 | 63.52 | $7.14 | 8.89 |
| 2023-08-31 | 63.96 | $2.49 | 25.65 |
| 2023-02-28 | 102.34 | $3.04 | 33.72 |
| 2022-11-30 | 69.87 | $-2.87 | 0.00 |
| 2022-08-31 | 72.82 | $-5.39 | 0.00 |
| 2022-05-31 | 67.96 | $-5.11 | 0.00 |
| 2022-02-28 | 87.38 | $-2.49 | 0.00 |
| 2021-11-30 | 97.83 | $-2.06 | 0.00 |
| 2021-08-31 | 68.85 | $2.67 | 25.77 |
| 2021-05-31 | 77.55 | $-2.53 | 0.00 |
| 2021-02-28 | 81.56 | $-4.50 | 0.00 |
| 2020-11-30 | 72.20 | $2.62 | 27.60 |
| 2020-08-31 | 61.38 | $-2.06 | 0.00 |
| 2020-05-31 | 56.44 | $1.87 | 30.12 |
| 2020-02-29 | 51.74 | $2.50 | 20.70 |
| 2019-11-30 | 45.62 | $-1.72 | 0.00 |
| 2019-08-31 | 28.56 | $-1.16 | 0.00 |
| 2019-05-31 | 33.17 | $-0.19 | 0.00 |
| 2019-02-28 | 35.93 | $0.79 | 45.52 |
| 2018-11-30 | 34.09 | $0.64 | 53.31 |
| 2018-08-31 | 28.51 | $1.85 | 15.41 |
| 2018-05-31 | 30.27 | $1.85 | 16.37 |
| 2018-02-28 | 32.58 | 0 | 0.00 |
| 2017-11-30 | 35.30 | 0 | 0.00 |
| 2017-08-31 | 31.67 | 0 | 0.00 |
| 2017-05-31 | 32.56 | 0 | 0.00 |
| 2017-02-28 | 32.34 | 0 | 0.00 |
| 2016-11-30 | 28.55 | 0 | 0.00 |
| 2016-08-31 | 21.09 | 0 | 0.00 |
| 2016-05-31 | 19.99 | 0 | 0.00 |
| 2016-02-29 | 15.80 | 0 | 0.00 |
| 2015-11-30 | 12.49 | 0 | 0.00 |
| 2015-08-31 | 12.92 | 0 | 0.00 |
| 2015-05-31 | 14.47 | 0 | 0.00 |
| 2015-02-28 | 13.35 | 0 | 0.00 |
| 2014-08-31 | 6.96 | 0 | 0.00 |
| 2014-05-31 | 6.75 | 0 | 0.00 |
| 2013-08-31 | 4.94 | 0 | 0.00 |
| 2013-05-31 | 5.28 | 0 | 0.00 |
| 2012-05-31 | 7.87 | 0 | 0.00 |
| 2012-02-29 | 7.25 | 0 | 0.00 |
| 2011-11-30 | 5.76 | 0 | 0.00 |
| 2011-08-31 | 5.00 | 0 | 0.00 |
| 2011-02-28 | 6.65 | 0 | 0.00 |
| 2010-11-30 | 6.65 | 0 | 0.00 |
| 2009-11-30 | 9.87 | 0 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $0.034B | $0.049B |
| BIOQUAL, Inc., formerly Diagnon Corporation, develops, produces and sells diagnostic test kits incorporating monoclonal antibodies to diagnose certain anemias, infections, and parasitic diseases. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $29.514B | 13.37 |
| Quest Diagnostics (DGX) | United States | $21.197B | 19.44 |
| Elanco Animal Health (ELAN) | United States | $11.500B | 24.35 |
| Encompass Health (EHC) | United States | $10.662B | 19.64 |
| DaVita (DVA) | United States | $10.023B | 13.82 |
| Chemed (CHE) | United States | $5.639B | 19.57 |
| Option Care Health (OPCH) | United States | $4.553B | 18.71 |
| RadNet (RDNT) | United States | $4.302B | 142.13 |
| LifeStance Health (LFST) | United States | $2.495B | 320.00 |
| Addus HomeCare (ADUS) | United States | $1.719B | 16.61 |
| Astrana Health (ASTH) | United States | $1.536B | 31.40 |
| Aveanna Healthcare Holdings (AVAH) | United States | $1.353B | 12.20 |
| U.S Physical Therapy (USPH) | United States | $1.157B | 29.19 |
| Pennant (PNTG) | United States | $1.072B | 31.31 |
| Daxor (DXR) | United States | $0.048B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.032B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |